IgG4 immune response in Churg-Strauss syndrome

Annals of the Rheumatic Diseases

Volumn 71, Issue 3, 2012, Pages 390-393

  Vaglio, Augusto ^a   Strehl, Johanna D ^b   Manger, Bernhard ^b   Maritati, Federica ^a   Alberici, Federico ^a   Beyer, Christian ^b   Rech, Jürgen ^b   Sinico, Renato A ^c   Bonatti, Francesco ^a   Battistelli, Luisita ^d   Distler, Jörg H W ^b   Schett, Georg ^b   Zwerina, Jochen ^b,e  

^a UNIVERSITY OF PARMA   (Italy)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c SAN CARLO BORROMEO HOSPITAL   (Italy)

^d UNIVERSITY HOSPITAL OF PARMA   (Italy)

^e HANUSCH HOSPITAL   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G4; IMMUNOGLOBULIN M; IMMUNOSUPPRESSIVE AGENT;

ADULT; AGED; ALLERGIC ASTHMA; ARTICLE; AUTOIMMUNE DISEASE; BIRMINGHAM VASCULITIS ACTIVITY SCORE; CELL INFILTRATION; CHRONIC SINUSITIS; CHURG STRAUSS SYNDROME; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ACTIVITY; EOSINOPHILIA; FEMALE; GRANULOMATOSIS; GRANULOMATOSIS WITH POLYANGIITIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN PRODUCTION; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; LONGITUDINAL STUDY; MALE; PLASMA CELL; PRIORITY JOURNAL; REMISSION; SCORING SYSTEM; WEGENER GRANULOMATOSIS;

ADOLESCENT; ADULT; AGED; ASTHMA; CASE-CONTROL STUDIES; CHURG-STRAUSS SYNDROME; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULINS; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; WEGENER GRANULOMATOSIS; YOUNG ADULT;

EID: 84857231796     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2011.155382     Document Type: Article

References (20)

1. Pagnoux C, Guilpain P, Guillevin L. Churg-Strauss syndrome. Curr Opin Rheumatol 2007;19:25-32.
2. Vaglio A, Casazza I, Grasselli C, et al. Churg-Strauss syndrome. Kidney Int 2009;76:1006-11.
3. Vaglio A, Martorana D, Maggiore U, et al. HLA-DRB4 as a genetic risk factor for Churg-Strauss syndrome. Arthritis Rheum 2007;56:3159-66. (Pubitemid 47502764)
4. Dallos T, Heiland GR, Strehl J, et al. CCL17/thymus and activation-related chemokine in Churg-Strauss syndrome. Arthritis Rheum 2010;62:3496-503.
5. Zwerina J, Bach C, Martorana D, et al. Eotaxin-3 in Churg-Strauss syndrome: a clinical and immunogenetic study. Rheumatology (Oxford) 2011;50:1823-7.
6. Bottero P, Bonini M, Vecchio F, et al. The common allergens in the Churg-Strauss syndrome. Allergy 2007;62:1288-94. (Pubitemid 47537511)
7. de Moraes Lui C, Oliveira LC, Diogo CL, et al. Immunoglobulin G subclass concentrations and infections in children and adolescents with severe asthma. Pediatr Allergy Immunol 2002;13:195-202.
8. Khosroshahi A, Stone JH. A clinical overview of IgG4-related systemic disease. Curr Opin Rheumatol 2011;23:57-66.
9. Zen Y, Fujii T, Harada K, et al. Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis. Hepatology 2007;45:1538-46. (Pubitemid 46918338)
10. Suppiah R, Mukhtyar C, Flossmann O, et al. A cross-sectional study of the Birmingham vasculitis activity score version 3 in systemic vasculitis. Rheumatology (Oxford) 2011;50:899-905.
11. Guillevin L, Lhote F, Gayraud M, et al. Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients. Medicine (Baltimore) 1996;75:17-28. (Pubitemid 26041085)
12. Zen Y, Onodera M, Inoue D, et al. Retroperitoneal fibrosis: a clinicopathologic study with respect to immunoglobulin G4. Am J Surg Pathol 2009;33:1833-9.
13. Cartin-Ceba R, Keogh KA, Specks U, et al. Rituximab for the treatment of Churg-Strauss syndrome with renal involvement. Nephrol Dial Transplant 2011;26:2865-71.
14. Pepper RJ, Fabre MA, Pavesio C, et al. Rituximab is effective in the treatment of refractory Churg-Strauss syndrome and is associated with diminished T-cell interleukin-5 production. Rheumatology (Oxford) 2008;47:1104-5. (Pubitemid 351865947)
15. Yamamoto M, Takahashi H, Suzuki C, et al. Analysis of serum IgG subclasses in Churg-Strauss syndrome - the meaning of elevated serum levels of IgG4. Intern Med 2010;49:1365-70.
16. Brouwer E, Tervaert JW, Horst G, et al. Predominance of IgG1 and IgG4 subclasses of anti-neutrophil cytoplasmic autoantibodies (ANCA) in patients with Wegener's granulomatosis and clinically related disorders. Clin Exp Immunol 1991;83:379-86.
17. Sinico RA, Di Toma L, Maggiore U, et al. Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome. Arthritis Rheum 2005;52:2926-35. (Pubitemid 41369124)
18. Nirula A, Glaser SM, Kalled SL, et al. What is IgG4? A review of the biology of a unique immunoglobulin subtype. Curr Opin Rheumatol 2011;23:119-24.
19. Smyrk TC. Pathological features of IgG4-related sclerosing disease. Curr Opin Rheumatol 2011;23:74-9.
20. Strehl JD, Hartmann A, Agaimy A. Numerous IgG4-positive plasma cells are ubiquitous in diverse localised non-specific chronic inflammatory conditions and need to be distinguished from IgG4-related systemic disorders. J Clin Pathol 2011;64:237-43.